Welcome to LookChem.com Sign In|Join Free

CAS

  • or

79113-14-7

Post Buying Request

79113-14-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

79113-14-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 79113-14-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,9,1,1 and 3 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 79113-14:
(7*7)+(6*9)+(5*1)+(4*1)+(3*3)+(2*1)+(1*4)=127
127 % 10 = 7
So 79113-14-7 is a valid CAS Registry Number.

79113-14-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-nitrobenzyl N-(tert-butoxycarbonyl)glycinate

1.2 Other means of identification

Product number -
Other names Boc-Gly-ONb

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:79113-14-7 SDS

79113-14-7Relevant articles and documents

Synthesis and evaluation of a novel 99mTc-labeled bioreductive probe for tumor hypoxia imaging

Kimura, Sadaaki,Umeda, Izumi O.,Moriyama, Noriyuki,Fujii, Hirofumi

, p. 7359 - 7362 (2011)

Tumor hypoxia is closely associated with the malignant progression and/or the high metastatic ability of tumors and often induces resistance to chemo- and/or radiotherapy. Thus, the detection and evaluation of hypoxia is important for the optimization of

SYTHESIS OF RENIN INHIBITORS INVOLVING A CYCLOADDITION REACTION

-

Page/Page column 41, (2010/11/26)

The invention related to a novel process, novel process steps and novel intermediates useful in the synthesis of pharmaceutically active compounds, especially renin inhibitors, such as Aliskiren. Inter alia, the invention relates to a process for the manufacture of a compound of the formula (III), wherein R, R1, and R' are as defined in the specification, or a salt thereof, and a compound of formula (IV) wherein R, R1, R2 and R' are as defined in the specification, and processes of manufacturing these.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 79113-14-7